Cargando…

Strategies for Avoiding Typical Drug–Drug Interactions and Drug-Related Problems in Patients with Vascular Diseases

Background and objectives: Drug–drug interactions and drug-related problems in patients with vascular diseases are common. To date, very few studies have focused on these important problems. The aim of the present study is to investigate the most common drug–drug interactions and DRPs in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmelzer, Klaus Peter, Liebetrau, Dominik, Kämmerer, Wolfgang, Meisinger, Christine, Hyhlik-Dürr, Alexander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142821/ https://www.ncbi.nlm.nih.gov/pubmed/37109738 http://dx.doi.org/10.3390/medicina59040780

Ejemplares similares

Technical aspects of percutaneous endovascular arteriovenous fistula creation with the Ellipsys® Vascular Access System. Preliminary results after 16 patients
por: Liebetrau, Dominik, et al.
Publicado: (2023)

Valvulotomy of the great saphenous vein in ex situ non-reversed and in situ setting: a multicenter post-market study to assess the safety and efficacy of the AndraValvulotome™”
por: Souri, Yaser, et al.
Publicado: (2023)

Behandlungsstrategien und Ergebnisse bei injektionsassoziierten inguinalen perivaskulären Abszessen bei intravenös Drogenabhängigen
por: Liebetrau, D., et al.
Publicado: (2020)

Ressourcenbedarf bei der chirurgischen Behandlung von COVID‑19-Patienten in der universitären Maximalversorgung
por: Kerndl, H., et al.
Publicado: (2021)

The prevalence of vascular complications in SARS-CoV-2 infected outpatients
por: Goßlau, Yvonne, et al.
Publicado: (2022)

Post-COVID-19 Syndrome in Non-Hospitalized Individuals: Healthcare Situation 2 Years after SARS-CoV-2 Infection
por: Kirchberger, Inge, et al.
Publicado: (2023)

Subjective and Objective Cognitive Impairments in Non-Hospitalized Persons 9 Months after SARS-CoV-2 Infection
por: Kirchberger, Inge, et al.
Publicado: (2023)

Training in vascular trauma surgery for non-vascular surgeons: Vascular trauma surgery skills course
por: Engelhardt, M., et al.
Publicado: (2023)

Elevated Plasma D-Dimer Concentrations in Adults after an Outpatient-Treated COVID-19 Infection
por: Meisinger, Christa, et al.
Publicado: (2022)

Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – Erste Daten
por: Zerwes, Sebastian, et al.
Publicado: (2020)

Erratum zu: Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – Erste Daten
por: Zerwes, Sebastian, et al.
Publicado: (2020)

Die Marginalvene – nach wie vor eine seltene Entität: Fallserie von 16 Patienten
por: Liebetrau, D., et al.
Publicado: (2022)

Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients
por: Meisinger, Christa, et al.
Publicado: (2022)

The association between the number of symptoms and the severity of Post-COVID-Fatigue after SARS-CoV-2 infection treated in an outpatient setting
por: Schmidbauer, Lena, et al.
Publicado: (2023)

Drug–Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications
por: Di Mizio, Giulio, et al.
Publicado: (2021)

Cold-Start Problems in Data-Driven Prediction of Drug–Drug Interaction Effects
por: Dewulf, Pieter, et al.
Publicado: (2021)

Optimising Seniors’ Metabolism of Medications and Avoiding Adverse Drug Events Using Data on How Metabolism by Their P450 Enzymes Varies with Ancestry and Drug–Drug and Drug–Drug–Gene Interactions
por: Thomas, Roger E.
Publicado: (2020)

The Problems of Anticoagulant Control—1. Drug Interactions
por: Hamblin, T. J.
Publicado: (1970)

Pharmacogenetics to Avoid Adverse Drug Reactions
por: López-Fernández, Luis A.
Publicado: (2022)

In Vitro Investigation of Binding Interactions between Albumin–Gliclazide Model and Typical Hypotensive Drugs
por: Zurawska-Plaksej, Ewa, et al.
Publicado: (2021)

Adherence to Drug Label Recommendations for Avoiding Drug Interactions Causing Statin-Induced Myopathy–A Nationwide Register Study
por: Settergren, Jennifer, et al.
Publicado: (2013)

Therapeutic Strategies and Drug Development for Vascular Cognitive Impairment
por: Smith, Eric E., et al.
Publicado: (2017)

Pharmacokinetic Drug–Drug Interactions and Herb–Drug Interactions
por: Choi, Min-Koo, et al.
Publicado: (2021)

PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
por: Spanakis, Marios, et al.
Publicado: (2019)

Precision dosing to avoid adverse drug reactions
por: Polasek, Thomas M., et al.
Publicado: (2019)

Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis
por: Debus, Jane Louisa, et al.
Publicado: (2022)

The Problem of Drug Addiction
Publicado: (1940)

Predicting Drug-Target Interactions Using Drug-Drug Interactions
por: Kim, Shinhyuk, et al.
Publicado: (2013)

Tepotinib Inhibits Several Drug Efflux Transporters and Biotransformation Enzymes: The Role in Drug-Drug Interactions and Targeting Cytostatic Resistance In Vitro and Ex Vivo
por: Vagiannis, Dimitrios, et al.
Publicado: (2021)

Drug development: successes, problems and pitfalls—the industry perspective
por: Wein, Wolfgang
Publicado: (2016)

Drug-drug interactions in the ICU
por: Ray, S, et al.
Publicado: (2009)

Drug-drug interactions with raltegravir
por: Burger, David M
Publicado: (2009)

Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
por: Bahar, Muh. Akbar, et al.
Publicado: (2020)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug–Drug Interactions: Drug–Gene, Drug–Gene–Gene and Drug–Drug–Gene Interactions
por: Hahn, Martina, et al.
Publicado: (2021)

Screening for severe drug-drug interactions in patients with multiple sclerosis: A comparison of three drug interaction databases
por: Hecker, Michael, et al.
Publicado: (2022)

ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective
por: Tsaioun, Katya, et al.
Publicado: (2009)

Avoiding drug resistance through extended drug target interfaces: a case for stapled peptides
por: Wei, Siau Jia, et al.
Publicado: (2016)

Protecting Patients from Adverse Drug Events: Propoxyphene, PIMs, and Drugs to Avoid in Older Adults
por: Curtiss, Frederic R., et al.
Publicado: (2011)

Look-Alike Drugs: Avoiding Potential Medical Errors
por: Gangakhedkar, Gauri R., et al.
Publicado: (2019)

Understanding and preventing drug–drug and drug–gene interactions
por: Tannenbaum, Cara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nfn8952g2vpf3r4n2ttv006r02